JASON HULING: Open Payments
NPI 1144939323 · LOMA LINDA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,009 in 127 payments from 15 companies in 2025. Trend: 2023 $1,410 · 2024 $5,525 · 2025 $3,009
Food & beverage: $3,009
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 10 | $525 |
| Arcutis Biotherapeutics, Inc. | 10 | $350 |
| ABBVIE INC. | 37 | $335 |
| Incyte Corporation | 15 | $329 |
| LEO Pharma Inc. | 12 | $328 |
| Botanix SB Inc | 5 | $320 |
| Amgen Inc. | 15 | $168 |
| GENZYME CORPORATION | 2 | $150 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $136 |
| PFIZER INC. | 6 | $102 |
Products named: Bimzelx, Zoryve, OPZELURA, SOFDRA, ANZUPGO, DUPIXENT, SKYRIZI, OTEZLA.
Industry payments across CA — which companies pay providers there.
